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Gene transfer of metalloproteinase transin induces aberrant
behavior of cultured mesangial cells
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Gene transfer of metalloprotelnase transin induces aberrant behavior
of cultured mesangial cells. The aim of the present study is to clarify
whether the cellular expression of a matrix-degrading metalloprotein-
ase, transin, alters the behavior of cultured mesangial cells (MCs). The
cDNA encoding rat transin was introduced into rat MCs and tran-
scribed under the control of a Rous sarcoma virus promoter. The
resulting transfectants were then investigated for cell shape, migration,
proliferation, and expression of genes associated with matrix metabo-
lism. Northern blot analysis routinely detected the transin transcript in
two separate transfectants, MeTRN2 and MeTRN5. Transin expression
was strong in MeTRN2, moderate in MeTRN5, but absent in mock
transfectants. Immunoblot analysis revealed that these transin trans-
fectants synthesized 59 and 62 kDa molecules, which correspond to
transin gene products. Casein digestion assay detected enhanced pro-
teolytic activity in MeTRN2 and MeTRN5. Microscopically, the trans-
fected cells were somewhat elongated with accentuated margins com-
pared with mock transfectants. [3H]-thymidine uptake studies revealed
accelerated growth of the transfectants on a plastic substratum as well
as within gel matrix. The migration of the transfectants into gel matrix
was also significantly enhanced compared with that of mock transfec-
tants. No obvious alteration, however, was found in transcripts of
procollagen al(IV), laminin B2, or the metalloproteinase inhibitor
TIMP. We hypothesize that the metalloproteinase transin has a poten-
tial for affecting the behavior of MCs and contributing to the pathogen-
esis of glomerular injury.
Extracellular matrix (ECM) regulates the behavior of many
cell types and, thereby, contributes to organ development,
tissue repair, and maintenance of normal tissue structure and
function [1]. In the renal glomeruli, ECM may also play an
important role in the regulation of cell behavior and the main-
tenance of glomerular architecture. We previously reported that
the three-dimensional environment of basement membrane-
type matrix inhibits elongation, proliferation, and migration of
mesangial cells (MCs) in vitro [2]. Normal mesangial matrix
may then have an intrinsic potential for repressing the abnormal
behavior of MCs. However, the mesangial matrix is degraded
by matrix proteinases, especially by metalloproteinases. The
resulting failure of ECM to perform its regulatory function
could permit deviant behavior by MCs. Several lines of evi-
dence support this hypothesis: (i) Various matrix-degrading
proteinases can modulate the shape and growth of cells in vitro
[3—6]. (ii) Habu venom, a member of the metalloproteinase
family, can induce mesangiolysis followed by marked MC
proliferation in vivo [7]. (iii) Metalloproteinase expression in the
mesangium is closely associated with MC proliferation in an
experimental model of glomerulonephritis [8]. Therefore, me-
talloproteinases may play a pathological role not only in the
abnormal turnover of mesangial matrix, but also in the aberrant
behavior of MCs.
Our previous report demonstrated that cultured rat MCs
stimulated by IL-i, one of major players involved in the
pathogenesis of glomerular diseases [9—12], abundantly ex-
pressed transin (rat stromelysin) [13]. Transin is a metallopro-
teinase of broad substrate-specificity, capable of degrading
collagens, glycoproteins, and proteoglycans [14], all of which
are major constituents of the mesangial matrix and glomerular
basement membrane (GBM). Indeed, Bejarano and colleagues
[15] reported that stromelysin degrades glomerular ECM effec-
tively in vitro.
Therefore, we undertook the present study to clarify how the
multipotent matrix-degrader, transin, when expressed in a
dysregulated manner, affects the behavior of MCs. Using in
vitro gene transfer technology, we established clones of MCs
stably expressing transin, and assessed their behavioral char-
acteristics within ECM as well as on a plastic substratum.
Methods
Experimental design
A full-length cDNA of rat transin was subcloned into a
eukaryotic expression vector, pRc/RSV, and transfected into
rat MCs by a calcium-phosphate method. Stable transfectants
were selected in the presence of a neomycin analog G418, and
their expression of the transin transcript and of its product was
confirmed by RNA blot analysis or immunoblot analysis. Pro-
teolytic activity of transfectants was also examined using a
casein digestion assay. Then, we assessed these cells' changes
in shape, proliferation, migration, and expression of genes
associated with matrix metabolism by the methods described
below.
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Mesangial cells
Rat mesangial cells (MCs) from isolated glomeruli of adult
Sprague-Dawley rats were cultured as previously reported [16].
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Fig. 1. Expression of transin in the established stable transfectants.
A transin eDNA introduced into the expression vector pRcIRSV was
transfected to a rat mesangial cell (MC) clone 1-2, and the stable
transfectants, MeTRN2 and MeTRN5, were thus established.
MeCONI and MeCON3 were mock transfectants. A. Analysis of
transin transcript by Northern blotting. Positions of 28S and 18S
ribosomal RNAs are indicated to the left. B. Analysis of transin gene
product by immunoblotting. Molecular size standards are shown to
the left. C. Analysis of proteolytic activity by casein digestion assay.
The cleavage of fluorescein isothiocyanate (FITC)-labeled casein by
the transfectants was measured using a fluorometer. Data (means
sa) subtracted in the background were expressed as percentages
against the mean value of mock transfectants (control; 100%).
Asterisks show statistical significance (P < 0.05) compared with the
control.
Since cultured MCs may contain heterogeneous populations,
we used an MC clone specifically for the transfection study.
Clone 1-2 was established by limiting dilution from the cultured
rat MCs. This clone was confirmed as MCs by positive staining
for actin and desmin, and negative staining for cytokeratin and
factor VIII [16]. The MCs were maintained and all assays were
performed in Dulbecco's modified Eagle's medium (DMEM;
GIBCO) supplemented with 100 U/ml penicillin, 100 jsg/ml
streptomycin, and 5% fetal calf serum (FCS; Cell Culture
Laboratories).
Construction of recombinant plasmids and establishment of
stable transfectants
The Eco RI fragment of a full-length rat transin cDNA [171 (a
gift from Dr. L. M. Matrisian, Vanderbilt University, Nash-
ville, Tennessee, USA) was blunt-ended and introduced into a
blunt-ended Hind III site of pRc/RSV (Invitrogen) in a sense
orientation (pRc/RSVTR). A recombinant plasmid with an
insert of an anti-sense orientation (pRc/RSVATR) was prepared
as a control. All the plasmids were purified twice by CsCI
gradient centrifugation and used for transfection.
By using a modified calcium-phosphate method [18], clone
1-2 was transfected with pRc/RSVTR, pRc/RSVATR, or pRc/
RSV. Stable transfectants were selected in the presence of
G418 (Sigma; 0.75 mglml). Five clones examined in this study
were as follows: two sense transin transfectants, MeTRN2 and
MeTRN5; one anti-sense transin transfectant, MeATR2; and
two mock transfectants, MeCON1 and MeCON3. These trans-
fectants were assessed during the period between the 10th and
20th passages.
Assessment of transin expression
Northern blot analysis. To assess transin gene expression in
transfectants, total RNA was extracted by a single-step method
[19], and Northern blot analysis was performed as described
before [20]. The RNA samples (10 jsg/lane) were electropho-
resed on 1.2% agarose gels containing 10% formaldehyde, and
transferred onto nitrocellulose membranes (Schleicher &
Schuell, FRG). For the hybridization, Eco RI fragment of
transin cDNA was labeled with 32P-dCTP using a random
priming method [21]. These membranes were hybridized with
probes at 65°C for 16 hours in a solution containing 4x SSC (600
m sodium chloride, 60 m sodium citrate), 5 x Denhardt's
solution, 10% dextran sulfate, and 100 jsg/ml herring sperm
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Fig. 2. Effect of transin expression on the shape of MCs. Each transfectant was cultured on a plastic substratum for three days, and morphological
study was performed by phase-contrast microscopy. MeATR2 was a transin transfectant in the anti-sense orientation.
DNA. Afterward, the hybridized membranes were washed four
times in 4x SSC/0.1% SDS at 50°C, and exposed to Kodak
XAR film with an intensifying screen at —70°C.
Immunoblot analysis. To detect the translational product of
the transin cDNA, immunoblot analysis was performed by an
immunoperoxidase method. Each confluent transfectant (1 x
106 cells) was washed with PBS and harvested by using a rubber
policeman. Cell pellets were suspended in 200 1d lysis buffer
[2% digitonin, 0.5 M sucrose, 2 mrx EDTA(2Na), 20 mrs PBS,
pH 7.2, 0.02% sodium azide], and incubated on ice for 15
minutes. After centrifugation, an equal volume of 2 x SDS
gel-loading buffer (100 mM Tris-HC1, pH 6.8, 200 mtvs dithio-
threitol, 4% SDS, 0.2% bromophenol blue, 20% glycerol) was
added to each supernatant, and 10 p1 of sample was separated
on a 15% SDS-polyacrylamide gel. Proteins were electrotrans-
ferred to nitrocellulose membranes (Schleicher & Schuell). The
filters were blocked in 10% nonfat milk, incubated with sheep
anti-human matrix metalloproteinase (MMP)-3 antiserum (a gift
from Dr. Y. Okada, Kanazawa University, Tokyo, Japan)
diluted 1:500 in PBS containing 1% milk at 37°C for one hour,
washed with PBS, and incubated with peroxidase-conjugated
anti-sheep immunoglobulins (DAKO, Denmark) diluted 1:200 in
PBS. The enzymatic reaction was performed in 0.1 M Tris-HC1
containing 0.2 mg/ml of diaminobenzidine (Sigma) and 0.02%
H202.
Casein digestion assay. Casein is commonly used to measure
stromelysin activity because this substrate is minimally influ-
enced by ubiquitous metalloproteinases, type IV collagenases.
To examine the proteolytic activity of the stable transfectants,
we directly applied fluorescein isothiocyanate (FITC)-labeled
casein (Sigma) [22] to the culture of the transfectants. FITC-
casein was dissolved in 5% FCS/DMEM at a concentration of
50 g/ml, sterilized using 0.2 tm filter (Corning), and 1 ml of its
aliquot was added to each confluent culture of mock or transin
transfectants in 6-well plates. Wells without cells but containing
1 ml casein media were used for assessing background. After
incubating for 18 hours at 37°C, 1 ml of 10% trichloroacetic acid
(TCA) was added to each medium to remove uncleaved casein.
The TCA-insoluble protein was sedimented by centrifugation,
and a 150 p1 aliquot of each supernatant was mixed with an
equal volume of 1 M Tris. Fluorescence was determined by a
fluorometer (Fluoroskan II; Flow Laboratories) using an exci-
tation wavelength of 485 nm and an emission wavelength 538
nm. In transin transfectants, the individual values subtracted in
the background were compared with the values for mock
transfectants. The assay was performed in quadruplicate.
Assessment of cell behavior
Cell shape. Each transfectant (5 x iocells) was cultured on
a 35 mm plastic plate (Nunc Inc.) for three days. Cell shape was
examined in a phase-contrast microscope.
Growth. (i) Growth on a plastic substratum. Each transfec-
tant was suspended in 5% FCS/DMEM and dispensed into
96-well culture plates at a density of 1 x l0 cells per well. After
three days' culture, [3H]-thymidine (0.1 Ci per well) was
added to each well. Two days later, cells were harvested, and
incorporation of [3H]-thymidine was measured by a liquid
scintillation counter as an indicator of cell growth. The study
was performed in quadruplicate.
(ii) Growth in gel matrix. Each transfectant was placed into a
mixed gel composed of 25% Matrigel'TM (Collaborative Re-
search) and 75% type I collagen gel (derived from rat tail tendon
[16]) then assayed as reported previously [2]. In brief, each well
of a 96-well culture plate was coated with 50 p1 of mixed gel
solution without cells. After the gel formed, 50 j.d of mixed gel
solution containing 2 x iO cells was overlaid on the basal layer.
After the second gel formed, 100 p1 of 10% FCSIDMEM were
dispensed into each well to adjust the final concentration to 5%
FCS. Cells were precultured for three days, then pulsed with
[3H}-thymidine, 0.1 pCi per well. Three days later, the gel
matrix containing cells was harvested with extensive washing,
and the incorporation of [3H]-thymidine was assessed. All
experiments done were in quadruplicate.
MeCON1 MeCON3 MeTRN2 MeCON3
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Migration. To evaluate cell migration into gel matrix, we
used an assay system established previously [2]. A sterilized
polypropylene ring was attached to the center of each 35 mm
culture dish, separating the dish into two compartments. After
5 d of Matrigel was placed in the center of the inner area and
gelled, each transfectant was suspended in 5% FCS/DMEM at
a concentration of 1 x io cells/mi, plated into the outer area,
and incubated for two days. After exchanging the medium in
each outer area, the ring was removed to permit cell migration
toward the central gel area. Twelve days later, the extent of cell
migration into the gel area was assessed by phase-contrast
microscopy. To evaluate this migration quantitatively, four
axes at 450 angles to one another were randomly chosen on each
gel, and eight migratory distances from gel edge to migration
front were measured along each axis. The means of these values
were used as an index for migration activity. The assay was
performed in quadruplicate.
Expression of genes associated with matrix metabolism. To
assess the effect of transin introduction on the expression of
other genes associated with matrix metabolism, transcripts of
procollagen al(IV), laminin B2, transin, and tissue inhibitor of
metalloproteinases (TIMP) were investigated by Northern blot
analysis. The cDNA probes, mouse procollagen al (IV) and
mouse laminin B2 cDNAs were gifts from Dr. Y. Yamada
(NIH), and human TIMP cDNA from Dr. M. Naruto (Toray
Industries, Japan).
Statistical analysis
Data were expressed as means SE. Statistical analysis was
performed with the Mann-Whitney test.
Results
Expression of transin in the transfectants
To assess whether a transin gene introduced into rat MCs was
successfully transcribed, we first examined the transin tran-
script in two transfectants, MeTRN2 and 5, established for this
study. Northern blot analysis revealed that both transfectants
stably expressed 2 kb of transin mRNA; expression was higher
in MeTRN2 but still moderate in MeTRN5 (Fig. 1A). No
obvious expression of transin was detected in mock transfec-
tants, MeCON1 and MeCON3.
We then used immunoblot analysis to ascertain whether the
transcribed RNA was translated into protein in these transfec-
tants. Stromelysin, a human homologue of transin, is secreted
from cells in two latent forms, a molecule of 57 kDa and another
of 60 kDa; these unglycosylated and glycosylated species are
converted to an active form in the extracellular space [23].
Using anti-MMP-3 antibody, we detected 59 and 62 kDa mole-
cules in the transin transfectants (Fig. 1B), a size that approx-
imates the latent form of transin [241. These two molecules were
not detected in our mock transfectants but were markedly
induced in them by IL-lp (data not shown), a stimulator of
transin in MCs [13]. Additionally, the amount of transin de-
tected in the transfectants was closely associated with mRNA
level of transin (Fig. 1 A, B).
To determine whether the transin transfectants exhibit en-
hanced proteolytic activity, the cleavage of FITC-casein was
directly examined in culture. The casein digestion assay de-
tected increased proteolytic activity in MeTRN2 (195 25%)
C0
00.
0 0
MeCON1 MeCON3 MeTRN2 MeTRN5 MeATR2
Fig. 3. Effect of transin expression on the prolferaiion of MCs.
Growth activity of each transfectant on a plastic substratum (A) or in gel
matrix composed of 25% Matrigel and 75% type I collagen gel (B) was
assessed by the incorporation of [3H]-thymidine. Data are expressed as
means SE. Asterisks show statistical significance (P < 0.05) compared
with three different controls.
and in MeTRN5 (139 2%) compared with the mean value of
mock transfectants (Fig. lC). These findings showed that the
introduced transin cDNA was successfully transcribed, trans-
lated, and converted to an active enzyme in vitro.
Behavioral alteration in the transin transfectants
To investigate the phenotypic changes in transin transfec-
tants, we examined their shapes in a phase-contrast micro-
scope. In this experiment, identical numbers of transfected cells
were plated on a plastic substratum in the same culture condi-
tions. Both transin transfectants, MeTRN2 and MeTRNS, had
elongated shapes with accentuated cell margins (Fig. 2). In
contrast, the mock transfectants MeCON1 and MeCON3, and
the anti-sense gene transfectant MeATR2, showed a flattened
shape with vague cell margins.
Since a heightened proliferative response is one of the
representative pathological abnormalities of MCs observed in
glomerular diseases, we next investigated whether and how the
cell replication was affected by transin overexpression. On a
plastic substratum, proliferative activity was accelerated in
transin transfectants compared with controls (368 23% in
MeTRN2, and 220 4% in MeTRNS vs. the mean value of
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three controls; Fig. 3A). Within a matrix of 25% Matrigel and
75% collagen gel, the growth of transin transfectants was also
enhanced compared with that of the mock or anti-sense trans-
fectants (215 36% in MeTRN2, and 187 43% in MeTRN5
vs. the mean of controls; Fig. 3B). Additionally, the degree of
this accelerated growth in MeTRN2 and MeTRN5 correlated
closely with the amount of transin expressed, as shown in
Figure 1.
Another important abnormality of MC behavior in glomerular
disease is the migration of MCs along the GBM, which results
in "mesangial interposition." We, therefore, tested whether the
migration of MCs was significantly enhanced in transin trans-
fectants. The transfectants showed accelerated migration into
Matrigel, 367 68% in MeTRN2 and 231 26% in MeTRN5
against the mean value of mock transfectants (Fig. 4A). The
degree of the migration activity also correlated with the amount
of transin expressed (Fig. 4B).
Since abnormal matrix turnover in MCs also plays a critical
part in the pathogenesis of glomerular diseases, we investigated
the dynamics of the molecules involved in matrix metabolism in
transin transfectants. Northern blot analysis detected no obvi-
ous differences in the transcriptional level of procollagen
al(IV), laminin B2, or TIMP between transin transfectants and
mock transfectants (Fig. 5). These findings suggest that the gene
expression in transin transfectants was, as far as we investi-
gated, modified solely by transin overexpression, which had no
obvious effect on the transcripts of matrix components or their
degradation inhibitor, TIMP.
Discussion
Gene transfer technology is one of the most powerful strate-
gies available for elucidating unknown pathophysiological func-
tions of genes in vivo and in vitro. However, this technology has
rarely been applied in research on glomerular pathophysiology.
In the present study, we introduced the metalloproteinase
transin eDNA into cultured MCs using a eukaryotic expression
vector, pRc/RSV. Stable transfectants established in this way
expressed 2 kb of a transin transcript and two major forms of
transin, 59 and 62 kDa, respectively as described here. These
findings suggest that LTR derived from Rous sarcoma virus
works stably and efficiently to transcribe the exogenous gene in
MCs. This is further supported by the report of Thomas and
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Fig. 4. Effect of transin expression on the
migration of MCs. Migration activity into
Matngel was examined in each transfectant.
A. Phase-contrast microscopic analysis.
B. The degree of cell migration in each
transfectant was quantitatively assessed. Data
are expressed as means SE. Asterisks show
statistical significance (P < 0.05) compared
with both controls.
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Fig. 5. Effect of transin introduction on the expression of genes
associated with matrix metabolism in MCs. Steady-state mRNA level
of procollagen al(IV), laminin B2, and tissue inhibitor of metallopro-
teinases (TIMP) was examined by Northern blot analysis. Expression
of /3-actin gene was used as a loading control.
Dunn [25]. The 59 and 62 kDa molecules we detected in
transfectants apparently corresponded to the latent species of
transin, indicating that the transfected transin gene had been
transcribed in MCs in a dysregulated manner. Since the amount
of transin in our transfectants approximated the mRNA level in
transin, production may be regulated at the transcriptional
level. Additionally, casein digestion assay demonstrated that
this recombinant proteinase can be converted to an active
enzyme in culture.
Having successfully established these transfectants, we ex-
amined how their expression of transin, a multipotential matrix-
degrader, altered their behavior. The data presented here
suggest that the expression of transin induces proliferation and
enhanced migration of MCs, as well as altering them morpho-
logically compared with control MCs. Deduced from the fact
that transin is markedly induced in MCs stimulated by the
inflammatory cytokine IL-lp [13], this molecule may play a role
in altering the behavior of MCs as well as destructing ECM and,
thereby, contributing to the mesangial damage during glomeru-
lar diseases. Transin could modulate the behavior of MCs via
several mechanisms. (i) ECM may become degraded and unable
to exert its regulatory effect, thus permitting the aberrant
behavior of MCs. (ii) Transin can degrade ECM and release
several matrix fragments [15], some of which could act as
biological modulators for MCs and alter their behavior [26]. (iii)
Transin may alter the cell-to-cell or the cell-to-matrix interac-
tion by affecting the turnover of adhesion molecules, as re-
ported [271. (iv) Growth factors bound to matrix components
and stored in ECM [28] could be released as transin degrades
matrix components, facilitating their access to cell surface
receptors [29]. Furthermore, transin might be involved in the
conversion of a latent growth factor into the active form, as
suggested for other metalloenzymes [30]. (v) Since transin helps
to activate other matrix proteinases [31], such an interaction
may have enhanced the biological activity of the transin ob-
served here. (vi) The effect of transin on MCs could result from
acting as a growth factor, like the other proteolytic enzymes,
urokinase and thrombin [32, 33].
Several reports have suggested that the expression of transin/
stromelysin relates to phenotypic "transformation" of some
cells including tumor cells, synoviocytes, and vascular smooth
muscle cells [24, 34, 35]. These "transformed" cells play a
pivotal role in the pathogenesis of tumor invasion/metastasis,
rheumatoid arthritis, and atherosclerosis. In glomerular injury,
the involvement of metalloproteinases has been also suggested,
especially in the light of ECM damage and proteinuna [8, 36,
37]. Still unknown, however, is their contribution to the behav-
ioral abnormality of MCs including the proliferation and the
interposition, both of which are frequently observed in affected
glomeruli. Our present data offer insight into metalloprotein-
ases' potential for mediating the phenotypic "transformation"
of MCs during disease and for remodeling glomeruli. We
hypothesize here that the metalloproteinases may be involved
not only in abnormal degradation of the ECM, but also in the
aberrant behavior of MCs, both of which can contribute to the
pathogenesis of glomerular injury.
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